Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema (DELTA 2)

PHASE3CompletedINTERVENTIONAL
Enrollment

473

Participants

Timeline

Start Date

May 25, 2021

Primary Completion Date

December 27, 2022

Study Completion Date

January 6, 2023

Conditions
Chronic Hand Eczema
Interventions
DRUG

Delgocitinib cream

Cream for topical application

DRUG

Cream vehicle

The cream vehicle is similar to the delgocitinib cream except that it does not contain any active ingredient.

Trial Locations (50)

1000

LEO Investigational Site, Brussels

2400

LEO Investigational Site, Copenhagen

2650

LEO Investigational Site, Edegem

2900

LEO Investigational Site, Hellerup

3000

LEO Investigational Site, Leuven

6280

LEO Investigational Site, Loverval

8200

LEO Investigational Site, Aarhus

8500

LEO Investigational Site, Kortrijk

9000

LEO Investigational Site, Ghent

9990

LEO Investigational Site, Maldegem

15831

LEO Investigational Site, Mahlow

23538

LEO Investigational Site, Lübeck

28031

LEO Investigational Site, Madrid

30159

LEO Invesitgational Site, Hanover

33611

LEO Investigational Site, Mieres

41009

LEO Investigational Site, Seville

48013

LEO Investigational Site, Bilbao

48149

LEO Investigational Site, Münster

48455

LEO Investigational Site, Bad Bentheim

52074

LEO Investigational Site, Aachen

60590

LEO Investigational Site, Frankfurt

70178

LEO Investigational Site, Stuttgart

88045

LEO Investigational Site, Friedrichshafen

V3R 6A7

LEO Investigational Site, Surrey

V6H4E1

LEO Investigational Site, Vancouver

E3B 1G9

LEO Investigational Site, Fredericton

L1S 7K8

LEO Investigational Site, Ajax

K9A 4J9

LEO Investigational Site, Cobourg

M8X 1Y9

LEO Investigational Site, Etobicoke

L8S 1G5

LEO Investigational Site, Hamilton

M2M 4J5

LEO Investigational Site, Toronto

N2J 1C4

LEO Investigational Site, Waterloo

N8W 1E6

LEO Investigational Site, Windsor

07743

LEO Investigational Site, Jena

1105 AZ

LEO Investigational Site, Amsterdam

4614 VT

LEO Investigational Site, Bergen op Zoom

4818 CK

LEO Investigational Site, Breda

9713 GZ

LEO Investigational Site, Groningen

2134 TM

LEO Investigational Site, Hoofddorp

3584 CX

LEO Investigational Site, Utrecht

15-375

LEO Investigational Site, Bialystok

20-406

LEO Investigational Site, Lublin

35-055

LEO Investigational Site, Rzeszów

02-625

LEO Investigational Site, Warsaw

02-962

LEO Investigational Site, Warsaw

50-566

LEO Investigational Site, Wroclaw

51-318

LEO Investigational Site, Wroclaw

08915

LEO Investigational Site, Badalona

03010

LEO Investigational Site, Alicante

08041

LEO Investigational Site, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

LEO Pharma

INDUSTRY